Immunovia AB
IMMNOV
Rangering i aksjer
#34347
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aksjekurs
$0.00779541
Markedsverdi
$5.24M
Endring (1 dag)
1.58%
Endring (1 år)
-85.03%
Land
SE
Handel Immunovia AB (IMMNOV)
Kategori
Healthcare
Aksjeprishistorikk for Immunovia AB (IMMNOV)
Høyeste sluttskurs: $0.01 den 2026-10-01
Laveste sluttskurs: $6.16 den 2019-06-01
Laveste sluttskurs: $6.16 den 2019-06-01
Aksjeprishistorikk for Immunovia AB fra 2019 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -50.09% |
| 2025 | -2.79% |
| 2024 | -50.93% |
| 2023 | -90.35% |
| 2022 | -60.80% |
| 2021 | -55.60% |
| 2020 | 0.32% |
| 2019 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
